Robert J. Cobuzzi Jr.
Net Worth

Last updated:

What is Robert J. Cobuzzi Jr. net worth?

The estimated net worth of Dr. Robert J. Cobuzzi Jr. is at least $2,684,700 as of 31 Jan 2023. He has received compensation worth at least $2,684,700 in Diffusion Pharmaceuticals Inc..

What is the salary of Robert J. Cobuzzi Jr.?

Dr. Robert J. Cobuzzi Jr. salary is $536,940 per year as Pres, Chief Executive Officer & Director in Diffusion Pharmaceuticals Inc..

How old is Robert J. Cobuzzi Jr.?

Dr. Robert J. Cobuzzi Jr. is 60 years old, born in 1965.

What stocks does Robert J. Cobuzzi Jr. currently own?

As insider, Dr. Robert J. Cobuzzi Jr. owns shares in one company:

Company Title Shares Price per share Total value
Diffusion Pharmaceuticals Inc. (DFFN) Pres, Chief Executive Officer & Director 5,000 $0 $0

What does Diffusion Pharmaceuticals Inc. do?

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

Robert J. Cobuzzi Jr. insider trading

Diffusion Pharmaceuticals Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit 327 N/A N/A
Option
Common Stock 327 N/A N/A
Option
Common Stock 327 N/A N/A
Option
Restricted Stock Unit 327 N/A N/A
Option
Restricted Stock Unit 327 N/A N/A
Option
Common Stock 327 N/A N/A
Option
Common Stock 327 N/A N/A
Option
Restricted Stock Unit 327 N/A N/A
Purchase
Series C Convertible Preferred Stock 5,000 $0.5 $2,500
Option
Common Stock 16,350 N/A N/A
Option
Restricted Stock Unit 16,350 N/A N/A
Option
Common Stock 16,350 N/A N/A
Option
Restricted Stock Units 16,350 N/A N/A
Purchase
Common Stock 14,000 N/A N/A

Diffusion Pharmaceuticals key executives

Diffusion Pharmaceuticals Inc. executives and other stock owners filed with the SEC: